Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

89bio Inc (ETNB)

  • Event
  • May 12, 2022, 00:00 UTC
  • 24
  • 1 comments

(61% Neutral) 89bio, Inc. (ETNB) Reports Net Loss for 2022-03-31

Comment Full text

Altimmune Inc (ALT)

  • Event
  • May 12, 2022, 00:00 UTC
  • 25
  • 1 comments

(61% Neutral) ALTIMMUNE, INC. (ALT) Reports Net Loss for 2022-03-31

Comment Full text

Larimar Therapeutics Inc (LRMR)

  • Event
  • May 12, 2022, 00:00 UTC
  • 24
  • 1 comments

(28% Negative) LARIMAR THERAPEUTICS, INC. (LRMR) Reports 36% Loss Increase for 2022-03-31

Comment Full text

MeiraGTx Holding (MGTX)

  • Event
  • May 12, 2022, 00:00 UTC
  • 22
  • 1 comments

(61% Neutral) MeiraGTx Holdings plc (MGTX) Reports Net Loss for 2022-03-31

Comment Full text

Evelo Biosciences, Inc. (EVLO)

  • Event
  • May 12, 2022, 00:00 UTC
  • 12
  • 1 comments

(51% Neutral) Evelo Biosciences, Inc. (EVLO) Reports Net Loss for 2022-03-31

Comment Full text

Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS)

  • Event
  • May 12, 2022, 00:00 UTC
  • 13
  • 1 comments

(76% Positive) AKOUOS, INC. (AKUS) Reports 40% Loss Reduction for 2022-03-31

Comment Full text

Royalty Pharma (RPRX)

  • Event
  • May 11, 2022, 15:32 UTC
  • 22
  • 1 comments

(99% Neutral) Royalty Pharma plc (RPRX) Announces Business Combination

Comment Full text

Genmab (GMAB)

  • Event
  • May 11, 2022, 15:24 UTC
  • 13
  • 1 comments

(30% Negative) Genmab (GMAB) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

RedHill Biopharma (RDHL)

  • Event
  • May 11, 2022, 12:56 UTC
  • 14
  • 1 comments

(99% Neutral) RedHill Biopharma (RDHL) Files Form 6-K

Comment Full text

Absci Corporation (ABSI)

  • Event
  • May 11, 2022, 12:15 UTC
  • 18
  • 1 comments

(30% Negative) ABSCI CORP (ABSI) Reports Q2 2022 Financial Results

Comment Full text
  • Previous
  • 387
  • 388
  • 389
  • 390
  • 391
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228334)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140712)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin